United Airlines Holdings Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? United Airlines Holdings Inc trades at $99.6 (market cap $33.51B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: United Airlines Holdings Inc is far larger — about 18.6× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold United Airlines Holdings Inc for 46 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| UAL | VIR | |
|---|---|---|
Market Cap | $33.51B | $1.80B |
Volume | 5,035,282 | 1,782,836 |
Sector | Industrials | Health |
52-Week High | $136.11 | $11.78 |
52-Week Low | $85.21 | $5.12 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | $50.54B | $1.36B |
Signals from Pluang's Aura AI — not financial advice
United Airlines (UAL) trades at $103.21, down 1.18% on the day, with a bearish technical signal from moving averages but oversold RSI suggesting potential near-term support. Fundamentally, the stock appears undervalued with a P/E of 9.67 and P/S of 0.54, supported by consistent earnings beats and a 5.56% net margin. Recent news highlights aggressive customer acquisition efforts targeting Delta's premium flyers with status-match offers and Starlink WiFi enhancements.
The outlook is mixed: strong analyst consensus (66% buy ratings) and a $158.10 price target imply 53% upside, but rising fuel costs and bearish technicals pose near-term headwinds. Earnings growth and market share gains from strategic moves present opportunity, while operational execution and cost management remain key risks.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →